Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Christopoulos

Showing results (141-150 of 331) with videos related to

Pageof 34
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|March 28, 2013
Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cellsVimesh A Avlani, Wenting Ma, Hee-Chang Mun, et al.
Journal of Medicinal Chemistry|June 12, 2018
Subtle Modifications to the Indole-2-carboxamide Motif of the Negative Allosteric Modulator N-(( trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1 H)-yl)ethyl)cyclohexyl)-1 H-indole-2-carboxamide (SB269652) Yield Dramatic Changes in Pharmacological Activity at the Dopamine D<sub>2</sub> ReceptorAnitha Kopinathan, Christopher Draper-Joyce, Monika Szabo, et al.
The Journal of Biological Chemistry|June 27, 2007
Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligandsVimesh A Avlani, Karen J Gregory, Craig J Morton, et al.
Biochemical Pharmacology|November 20, 2015
Quantification of adenosine A(1) receptor biased agonism: Implications for drug discoveryJo-Anne Baltos, Karen J Gregory, Paul J White, et al.
Biochemical Pharmacology|September 10, 2018
Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonistsMadeleine M Fletcher, Michelle L Halls, Peishen Zhao, et al.
ACS Chemical Neuroscience|February 19, 2016
Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine ReceptorShailesh N Mistry, Herman Lim, Manuela Jörg, et al.
British Journal of Pharmacology|April 22, 2018
New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonismElizabeth A Vecchio, Jo-Anne Baltos, Anh T N Nguyen, et al.
Molecular Pharmacology|January 19, 2006
On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2Jesper Mosolff Mathiesen, Arthur Christopoulos, Trond Ulven, et al.
Journal of Medicinal Chemistry|September 3, 2010
Effects of conformational restriction of 2-amino-3-benzoylthiophenes on A(1) adenosine receptor modulationLuigi Aurelio, Celine Valant, Bernard L Flynn, et al.
Journal of Medicinal Chemistry|June 9, 2015
Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptorJeremy Shonberg, Christopher Draper-Joyce, Shailesh N Mistry, et al.
Pageof 34

Showing results (141-150 of 331) with videos related to

Sort By:
Pageof 34
American Journal of Physiology. Endocrinology and Metabolism|March 28, 2013
Calcium-sensing receptor-dependent activation of CREB phosphorylation in HEK293 cells and human parathyroid cellsVimesh A Avlani, Wenting Ma, Hee-Chang Mun, et al.
Journal of Medicinal Chemistry|June 12, 2018
Subtle Modifications to the Indole-2-carboxamide Motif of the Negative Allosteric Modulator N-(( trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1 H)-yl)ethyl)cyclohexyl)-1 H-indole-2-carboxamide (SB269652) Yield Dramatic Changes in Pharmacological Activity at the Dopamine D<sub>2</sub> ReceptorAnitha Kopinathan, Christopher Draper-Joyce, Monika Szabo, et al.
The Journal of Biological Chemistry|June 27, 2007
Critical role for the second extracellular loop in the binding of both orthosteric and allosteric G protein-coupled receptor ligandsVimesh A Avlani, Karen J Gregory, Craig J Morton, et al.
Biochemical Pharmacology|November 20, 2015
Quantification of adenosine A(1) receptor biased agonism: Implications for drug discoveryJo-Anne Baltos, Karen J Gregory, Paul J White, et al.
Biochemical Pharmacology|September 10, 2018
Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonistsMadeleine M Fletcher, Michelle L Halls, Peishen Zhao, et al.
ACS Chemical Neuroscience|February 19, 2016
Novel Fused Arylpyrimidinone Based Allosteric Modulators of the M1 Muscarinic Acetylcholine ReceptorShailesh N Mistry, Herman Lim, Manuela Jörg, et al.
British Journal of Pharmacology|April 22, 2018
New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonismElizabeth A Vecchio, Jo-Anne Baltos, Anh T N Nguyen, et al.
Molecular Pharmacology|January 19, 2006
On the mechanism of interaction of potent surmountable and insurmountable antagonists with the prostaglandin D2 receptor CRTH2Jesper Mosolff Mathiesen, Arthur Christopoulos, Trond Ulven, et al.
Journal of Medicinal Chemistry|September 3, 2010
Effects of conformational restriction of 2-amino-3-benzoylthiophenes on A(1) adenosine receptor modulationLuigi Aurelio, Celine Valant, Bernard L Flynn, et al.
Journal of Medicinal Chemistry|June 9, 2015
Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptorJeremy Shonberg, Christopher Draper-Joyce, Shailesh N Mistry, et al.
Pageof 34